PBPK Model of Morphine Incorporating Developmental Changes in Hepatic OCT1 and UGT2B7 Proteins to Explain the Variability in Clearances in Neonates and Small Infants
Morphine has large pharmacokinetic variability, which is further complicated by developmental changes in neonates and small infants. The impacts of organic cation transporter 1 (OCT1) genotype and changes in blood‐flow on morphine clearance (CL) were previously demonstrated in children, whereas chan...
Saved in:
Main Authors: | Chie Emoto (Author), Trevor N. Johnson (Author), Sibylle Neuhoff (Author), David Hahn (Author), Alexander A. Vinks (Author), Tsuyoshi Fukuda (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Using a Vancomycin PBPK Model in Special Populations to Elucidate Case‐Based Clinical PK Observations
by: Chie Emoto, et al.
Published: (2018) -
A Theoretical Physiologically‐Based Pharmacokinetic Approach to Ascertain Covariates Explaining the Large Interpatient Variability in Tacrolimus Disposition
by: Chie Emoto, et al.
Published: (2019) -
Novel Mechanistic PBPK Model to Predict Renal Clearance in Varying Stages of CKD by Incorporating Tubular Adaptation and Dynamic Passive Reabsorption
by: Weize Huang, et al.
Published: (2020) -
Guide to development of compound files for PBPK modeling in the Simcyp population‐based simulator
by: Udoamaka Ezuruike, et al.
Published: (2022) -
Hepatic OATP1B zonal distribution: Implications for rifampicin‐mediated drug-drug interactions explored within a PBPK framework
by: Mattie Hartauer, et al.
Published: (2024)